Skip to main content
Premium Trial:

Request an Annual Quote

Genewiz to Acquire Beckman Coulter's Genomic Services Business

NEW YORK (GenomeWeb) – Genomics service provider Genewiz said today that it has agreed to acquire Beckman Coulter's genomic services business.

The deal's financial terms were not disclosed. It has been approved by both boards and will close immediately, Genewiz added.

Beckman Coulter's genomic service business provides sequencing services — including comprehensive Sanger sequencing, next-generation sequencing, bioinformatics, and CLIA and clinical services — to healthcare businesses, academia, and government institutions. Genewiz chairman and CEO Steve Sun praised the deal in a statement today, saying the acquisition "is an ideal fit with Genewiz's global strategy and expansion plans."

Beckman Coulter's genomics services business has proven its leadership role in the market, Sun added, and its experts "have built an efficient workflow that allows for the delivery of quality and timely results to its customers. The integration of these two businesses will allow for an increased level of service and value to customers worldwide."